Market penetration Iris Interactive serves pharmaceutical and healthcare clients across 25 countries with a mature fifth-generation product, suggesting opportunities to upsell to larger pharma organizations or expand into additional regional markets where current users are active.

Product velocity Their software accelerates time to market and increases launch success, indicating potential for demand in teams focused on rapid product introduction, accelerated clinical to commercial handoffs, and expansion after initial deployment.

Value leverage Proven track record of boosting New Product Portfolio value by over 50% presents a compelling case for renewal, expansion of modules, or cross-sell of complementary solutions to existing customers seeking measurable ROI.

Global reach With 1000 staff trained internationally and presence in 25 countries, there are cross-border selling opportunities, channel partnerships, and localized support offerings to meet multinational client needs.

Industry fit Focus on marketing, clinical, R&D and sales teams within pharma/healthcare creates a clear target for expansion into adjacent life sciences segments and organizations seeking structured go-to-market enablement.